Cellectar Biosciences, Inc. Quarterly Costs and Expenses in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cellectar Biosciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q1 2024.
  • Cellectar Biosciences, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $12M, a 37.9% increase year-over-year.
  • Cellectar Biosciences, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $42.3M, a 34.7% increase year-over-year.
  • Cellectar Biosciences, Inc. annual Costs and Expenses for 2023 was $39M, a 35.2% increase from 2022.
  • Cellectar Biosciences, Inc. annual Costs and Expenses for 2022 was $28.8M, a 19.4% increase from 2021.
  • Cellectar Biosciences, Inc. annual Costs and Expenses for 2021 was $24.1M, a 57.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $42.3M $12M +$3.3M +37.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $39M $12.5M +$5.13M +69.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $33.8M $9.41M +$1.6M +20.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $32.2M $8.29M +$858K +11.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $31.4M $8.71M +$2.57M +41.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $28.8M $7.42M +$1.5M +25.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $27.3M $7.82M +$2M +34.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $25.3M $7.44M +$1.41M +23.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $23.9M $6.14M -$219K -3.45% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $24.1M $5.92M +$2.12M +55.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $22M $5.82M +$1.91M +48.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $20.1M $6.03M +$2.41M +66.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $17.7M $6.36M +$2.4M +60.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $15.3M $3.8M +$415K +12.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 $14.9M $3.91M -$53.9K -1.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $14.9M $3.62M +$422K +13.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $14.5M $3.96M +$329K +9.06% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $14.2M $3.38M -$500K -12.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $14.7M $3.96M +$876K +28.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $13.8M $3.2M +$295K +10.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $13.5M $3.63M +$176K +5.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $13.3M $3.88M -$204K -4.98% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 $13.5M $3.09M -$396K -11.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $13.9M $2.9M -$312K -9.69% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $14.2M $3.45M +$641K +22.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $13.6M $4.09M +$1.44M +54.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $12.2M $3.48M +$1.02M +41.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $11.1M $3.22M +$884K +37.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $10.3M $2.81M +$812K +40.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $9.45M $2.65M +$861K +48.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 $8.59M $2.47M +$375K +17.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $8.21M $2.33M +$41.8K +1.82% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $8.17M $2M -$587K -22.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $8.76M $1.79M -$466K -20.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $9.22M $2.09M -$181K -7.95% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $9.4M $2.29M -$254K -10% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $9.66M $2.59M -$232K -8.22% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $9.89M $2.25M -$1.8M -44.5% Oct 1, 2014 Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 $11.7M $2.27M -$637K -21.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $12.3M $2.55M -$177K -6.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $12.5M $2.82M +$107K +3.94% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 $12.4M $4.06M +$1.89M +87.5% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 $10.5M $2.91M +$856K +41.7% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-05-20
Q2 2013 $9.65M $2.72M +$511K +23.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $9.14M $2.71M +$386K +16.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $8.75M $2.16M +$145K +7.17% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 $8.61M $2.05M +$143K +7.48% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $8.47M $2.21M -$42.9K -1.91% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $8.51M $2.33M +$1.47M +173% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $7.04M $2.02M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 $1.91M +$1.3M +215% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $2.25M +$724K +47.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $854K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 $607K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $1.53M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.